Please use this identifier to cite or link to this item:
https://doi.org/10.2217/nnm.09.17
DC Field | Value | |
---|---|---|
dc.title | Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel | |
dc.contributor.author | Sun, B. | |
dc.contributor.author | Feng, S.-S. | |
dc.date.accessioned | 2014-10-09T07:05:06Z | |
dc.date.available | 2014-10-09T07:05:06Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Sun, B., Feng, S.-S. (2009). Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomedicine 4 (4) : 431-445. ScholarBank@NUS Repository. https://doi.org/10.2217/nnm.09.17 | |
dc.identifier.issn | 17435889 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/90423 | |
dc.description.abstract | Aims: We synthesized a novel system of docetaxel-loaded, tratuzumab-functionalized nanoparticles (NPs) of biodegradable copolymers for targeted and synergistic chemotheraphy. Material & Methods: NPs of two component biodegradable copolymers were prepared by a modified solvent extraction/evaporation method with D-α-tocopheryl polyethylene glycol succinate (TPGS) as emulsifier. One component copolymer is poly(lactide)-TPGS, which is of desire hydrophobic-lipophilic balance for cellular adhesion, and another is carboxyl group-terminated TPGS, which facities the conjugation of trastuzumab on the NP surface for targeting. Results: In vitro investigation with SK-BR-3 breast cancer cell of HER2 overexpression showed that the tratuzumab-functionalized NPs have great advantages over nude NPs in cellular uptake and cytotocity. Conclusion: Trastuzumab conjugated onto the NP surface has two functions: one is to target HER2-overexpressing cancer cells and the other is to enhance the cytotoxicity of docetaxel through synergistic effects. The trastusumab-functionalized, docetaxel-loaded NPs have great potential for targeted chemotheraphy to treat HER2-overexpressing cancer. © 2009 Future Medicine Ltd. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.2217/nnm.09.17 | |
dc.source | Scopus | |
dc.subject | Biodegradable polymers | |
dc.subject | Biomaterials | |
dc.subject | Cancer nanotechnology | |
dc.subject | Chemotherapeutic engineering | |
dc.subject | Drug delivery | |
dc.subject | Herceptin® | |
dc.subject | Nanobiotechnology | |
dc.type | Article | |
dc.contributor.department | CHEMICAL & BIOMOLECULAR ENGINEERING | |
dc.description.doi | 10.2217/nnm.09.17 | |
dc.description.sourcetitle | Nanomedicine | |
dc.description.volume | 4 | |
dc.description.issue | 4 | |
dc.description.page | 431-445 | |
dc.identifier.isiut | 000268005100014 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.